Results 71 to 80 of about 20,336 (222)

Association of Ca×PO4 product with levels of serum C-reactive protein in regular hemodialysis patients. [PDF]

, 2012
INTRODUCTION Numerous studies have attempted to identify risk factors for mortality and morbidity in maintenance hemodialysis patients. In this study we sought to examine the association of the levels of serum C-reactive protein (CRP) with value of Ca×
Nasri, H.
core   +1 more source

Acceptance and Preference of a Commercial Dry Renal Diet in Healthy Cats: An In‐Home Proof‐of‐Concept Trial

Journal of Animal Physiology and Animal Nutrition, EarlyView.
ABSTRACT Cats diagnosed with chronic kidney disease (CKD) have shown a better prognosis when consuming an appropriate renal diet, which makes its palatability a key factor in ensuring proper compliance. A proof‐of‐concept trial with a commercial dry renal diet was conducted in 33 healthy cats to assess its palatability over three consecutive 6‐day ...
Tomás Rodrigues Magalhães, Ronald Jan Corbee, Felisbina Luísa Queiroga, Ana Luísa Lourenço   +3 more
wiley   +1 more source

Efficacy and safety offerric citrate in treatment of hyperphosphatemia in patients with chronic kidney disease:a Meta-analysis

Linchuang shenzangbing zazhi, 2020
Objective To evaluate the efficacy and safety of ferric citrate in treatment of hyperphosphatemia in patients with chronic kidney disease（CKD）,and provide evidence-based basis for clinical medication.Methods The literature on randomized controlled trials（
WANG Shan-shan, WEN Tong, ZHANG Xin-zhou
doaj  

Pseudohypoparathyroidism type I-b with neurological involvement is associated with a homozygous PTH1R mutation [PDF]

, 2016
Pseudohypoparathyroidism type 1b (PHP1b) is characterized by hypocalcemia, hyperphosphatemia, increased levels of circulating parathyroid hormone (PTH), and no skeletal or developmental abnormalities.
Almeida, MR, Batista, S, Brás, J, Guerreiro, R, Hardy, J, Oliveira, C, Pires, P, Ribeiro, MH, Santana, I   +8 more
core   +1 more source

Application and Challenges of Chimeric Antigen Receptor T Cell Therapy in Systemic Rheumatic Diseases and Autoimmune Disorders

MedComm, Volume 7, Issue 4, April 2026.
CAR‐T cell therapy in systemic rheumatic diseases and autoimmune disorders. (This figure was created using BioRender.com.) ABSTRACT Chimeric antigen receptor T (CAR‐T) cell therapy, originally developed for hematologic malignancies, has emerged as a transformative candidate for systemic rheumatic diseases and autoimmune disorders (AIDs).
Zhidan Fan, Li Zhang, Haiguo Yu
wiley   +1 more source

Chronic Hyperphosphatemia and Vascular Calcification Are Reduced by Stable Delivery of Soluble Klotho [PDF]

, 2016
αKlotho (αKL) regulates mineral metabolism, and diseases associated with αKL deficiency are characterized by hyperphosphatemia and vascular calcification (VC).
Bhaskaran, Manoj, Cass, Taryn A., Clinkenbeard, Erica L., Cramer, Martin S., Hum, Julia M., Johnson, Robert L., O’Bryan, Linda M., Smith, Rosamund C., Tatiparthi, Arun K., White, Kenneth E., Wilson, Jonathan M.   +10 more
core   +1 more source

Safety of Ferric Citrate Hydrate in Pregnant Women With Iron Deficiency Anemia, Fetuses, and Newborns: A Real‐World, Observational, Post‐Marketing Surveillance Study

Journal of Obstetrics and Gynaecology Research, Volume 52, Issue 4, April 2026.
ABSTRACT Aim This post‐marketing surveillance study determined the real‐world use and safety of ferric citrate hydrate (FC) in fetuses and pregnant women with iron deficiency anemia (IDA). Methods Pregnant women with IDA were registered centrally and followed prospectively from the first FC administration until the end of pregnancy or at treatment ...
Shinichiro Suzuki, Teruo Hashimoto, Yuri Okuda, Kyoko Ito, Sayaka Ito, Masahiko Shigeta, Yuki Goto, Eiji Horikawa, Noriaki Nishino, Ryoichi Yamada   +9 more
wiley   +1 more source

Novel Treatments from Inhibition of the Intestinal Sodium–Hydrogen Exchanger 3

International Journal of Nephrology and Renovascular Disease, 2021
Csaba P Kovesdy,1 Adebowale Adebiyi,2 David Rosenbaum,3 Jeffrey W Jacobs,3 L Darryl Quarles1 1Division of Nephrology, University of Tennessee Health Science Center, Memphis, TN, USA; 2Department of Physiology, University of Tennessee Health Science ...
Kovesdy CP, Adebiyi A, Rosenbaum D, Jacobs JW, Quarles LD   +4 more
doaj  

Fibroblast growth factor-23 (FGF-23) / soluble Klotho protein (sKlotho) / sclerostin glycoprotein ratio disturbance is a novel risk factor for cardiovascular complications in ESRD patients receiving treatment with regular hemodialysis or hemodiafiltration [PDF]

Терапевтический архив, 2018
Aim of the study was to explore the role of the FGF-23/sKlotho/sclerostin ratio disturbance in the determining of cardiovascular risk in end stage renal disease (ESRD) patients, receiving treatment with regular hemodialysis (НD) or hemodiafiltration (НDF)
L Yu Milovanova, I A Dobrosmyslov, Yu S Milovanov, V V Fomin, M V Taranova, V V Kozlov, S Yu Milovanova, E I Kozevnikova   +7 more
doaj   +1 more source

Fibroblast growth factor 23 and cardiovascular disease in patients with chronic kidney disease [PDF]

, 2018
Chronic kidney disease (CKD) has been known to be associated with an increased risk of cardiovascular (CV) mortality and morbidity in Japan. Although traditional risk factors contribute to the development of CV disease in CKD patients, they cannot fully ...
NITTA Kosaku
core   +2 more sources